GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash and Bank History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash and Bank | ₹1,659 Cr | ₹1,160 Cr | ₹1,412 Cr | ₹1,139 Cr | ₹1,111 Cr |
What is the latest Cash and Bank ratio of GLENMARK PHARMACEUTICALS ?
Year | Cash and Bank |
---|---|
Mar2024 | ₹1,659 Cr |
Mar2023 | ₹1,160 Cr |
Mar2022 | ₹1,412 Cr |
Mar2021 | ₹1,139 Cr |
Mar2020 | ₹1,111 Cr |
How is Cash and Bank of GLENMARK PHARMACEUTICALS Trending?
Years | Cash and Bank | % Change | |
---|---|---|---|
Mar2024 | ₹1,659 Cr | 43.02 | |
Mar2023 | ₹1,160 Cr | -17.80 | |
Mar2022 | ₹1,412 Cr | 23.91 | |
Mar2021 | ₹1,139 Cr | 2.51 | |
Mar2020 | ₹1,111 Cr | - |
Compare Cash and Bank of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹41,438.2 Cr | -2% | -3.7% | 60.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,557.0 Cr | 2.3% | -0.8% | 32.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,994.0 Cr | 3.2% | 1.1% | 51.5% | Stock Analytics | |
CIPLA | ₹116,494.0 Cr | 0.3% | -2% | 10% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,297.0 Cr | -1.8% | 2.7% | 12.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,035.0 Cr | 2% | 1.5% | 38% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -2% |
-3.7% |
60.5% |
SENSEX | -1% |
-5% |
5.6% |
You may also like the below Video Courses